Real-time enrollment status for this primary biliary cholangitis clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 4:24 PM UTC
| NCT Number | NCT07216235 |
| Recruiting Status | Recruiting |
| Condition | Primary Biliary Cholangitis |
| Phase | PHASE3 |
| Target Enrollment | 386 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Zydus Therapeutics Inc. |
| Last Updated on CT.gov | August 4, 2026 (Aug 4, 2026) |
As of October 16, 2026: Clinical trial NCT07216235 is currently recruiting participants. This phase3 study for primary biliary cholangitis is actively seeking new participants at 3 locations across the United States. The study is sponsored by Zydus Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07216235 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07216235 was last updated Aug 4, 2026 (August 4, 2026). HelloStudys verifies this status automatically.